author-photo

Hasan Daoud

Boehringer Ingelheim

3

Papers

0

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG)

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Activity of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients (pts) with NSCLC with uncommon EGFR mutations: A real-world cohort study (UpSwinG).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB138: UpSwinG: real-world, non-interventional cohort study on TKI activity in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC with uncommon mutations

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)